Patent details

Basic Information

Publication number:

EP3378478

PCT Application Number:

CN2017072155

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177437027

PCT Publication Number:

WO2017129087

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION COMPRISING QUINOLINE DERIVATIVE OR SALT THEREOF

French Title of Invention:

COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ DE QUINOLÉINE OU UN SEL DE CELUI-CI

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT CHINOLINDERIVAT ODER SALZ DAVON

SPC Number:

Dates

Filing date:

23/01/2017

Grant date:

11/05/2022

EP Publication Date:

26/09/2018

PCT Publication Date:

03/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/05/2022

EP B1 Publication Date:

11/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/01/2023

Expiration date:

23/01/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/05/2022

 

 

Name:

Jiangsu Hengrui Medicine Co., Ltd.

Address:

No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang, Jiangsu 222047, China (CN)

Inventor

1

Name:

LU, Yun

Address:

China (CN)

2

Name:

WANG, Chenyang

Address:

China (CN)

3

Name:

ZHANG, Xinhua

Address:

China (CN)

Priority

Priority Number:

201610056739

Priority Date:

27/01/2016

Priority Country:

China (CN)

Classification

IPC classification:

A61K 31/4709; A61K 47/32; A61K 9/20; A61K 9/48; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202219

Publication date:

11/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages